Patients in the Alzheimer continuum were more often APOE ε4 carriers (60%) than patients with non-AD pathologic change (38%) and normal profile (30%) (p < 0.001, eTable 2, links.lww.com/WNL/C301). The gene discussed is APOE; the disease is Alzheimer disease.